Open AccessContralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy
Author(s) -
Nicole Christian,
Emily C. Zabor,
Michael R. Cassidy,
Jessica Flynn,
Monica Morrow,
Mary L. Gemignani
Publication year - 2019
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-019-08038-8
Subject(s) - surgical oncology , medicine , chemotherapy , mastectomy , oncology , neoadjuvant therapy , prophylactic mastectomy , breast cancer , general surgery , surgery , cancer
Neoadjuvant chemotherapy (NAC) for breast cancer increases breast-conserving surgery (BCS) rates, but many women opt for mastectomy with contralateral prophylactic mastectomy (CPM). Here we evaluate factors associated with CPM use in women undergoing mastectomy post-NAC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom